65th American Society of Hematology Annual Meeting and Exposition – Poster

Dec 11, 2023

Anti-leukemic Activity of Luveltamab Tazevibulin (LT, STRO-002), a Novel Folate Receptor-α (FR-α)-targeting Antibody Drug Conjugate (ADC) in Relapsed/Refractory CBFA2T3::GLIS2 AML 

Presenter & Primary Author: Dr. Soheil Meshinch